The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990–2019
Open accessAbstract
Background: Neurological disorders are a major and increasing global health challenge, which accounts for a substantial portion of the disease burden worldwide. The aim of this systematic analysis is to present the most comprehensive and up-to-date estimates of disease burden, epidemiological trends, and attributable risk factors of neurological disorders at global, regional, and national levels. Methods: We extracted data of 18 neurological disorders from the Global Burden of Disease 2019 study database. The burden of neurological disorders was measured using the incidence, prevalence, mortality, and disability-adjusted life years (DALYs), and further described according to age, sex, year, geographical location and socio-demographic Index (SDI). All estimates were presented with corresponding 95% uncertainty intervals (UIs). Findings: Globally, in 2019, there were nearly 10 million deaths and 349 million DALYs due to neurological disorders. Among the 18 neurological disorders, stroke was the biggest contributor to DALYs (143232.18 [95%UI 133095.81-153241.82] in thousands) and deaths (6552.72 [95%UI 5995.20-7015.14] in thousands), followed by neonatal encephalopathy due to birth asphyxia and trauma. From 1990 to 2019, the DALYs of neurological diseases belonging to the communicable, maternal, neonatal and nutritional categories showed a sharp decrease, while Alzheimer's disease and other dementias and Parkinson's disease showed a large increase. Neurological disorders exhibited different profiles in different regions and age groups. A significant correlation between the SDI and the age-standardized DALY rates was also found except for Alzheimer's disease and other dementias. In addition, risk factors such as high systolic blood pressure, low birth weight and short gestation period, and metabolic risk contribute significantly to neurological disorders. Interpretation: The overall burden of neurological disorders has increased from 1990 to 2019, especially for non-communicable neurological disorders. The substantial variations of burden across regions emphasize the need for region-specific interventional strategies and allocation of resources based on priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., Abbasifard, M., Abbasi-Kangevari, M., Abd-Allah, F., Abedi, V., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00252-0 · Cited by 7,937
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412
Feigin, V. L., Roth, G. A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Mensah, G. A., Norrving, B., Shiue, I., Ng, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30073-4 · Cited by 1,691
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
Muntner, P., Hardy, S. T., Fine, L. J., Jaeger, B. C., Wozniak, G., Levitan, E. B., & Colantonio, L. D. (2020) · JAMA · doi:10.1001/jama.2020.14545 · Cited by 964
Smart food policies for obesity prevention
Hawkes, C., Smith, T. G., Jewell, J., Wardle, J., Hammond, R. A., Friel, S., Thow, A. M., & Kain, J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61745-1 · Cited by 836
Balk, E. M., Earley, A., Raman, G., Avendano, E. A., Pittas, A. G., & Remington, P. L. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0452 · Cited by 371
The changing and dynamic epidemiology of meningococcal disease
Halperin, S. A., Bettinger, J. A., Greenwood, B., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P., Ramsay, M. E., & Sáfadi, M. A. P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.032 · Cited by 307
Murray, C. J., Lopez, A. D., Black, R., Ahuja, R., Ali, S. M., Baqui, A., Dandona, L., Dantzer, E., Das, V., Dhingra, U., et al. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-27 · Cited by 194 · cited 1×
“are unable to identify cause of death in many neurological disorders (19).”
BackgroundSingh, G., Sharma, M., Kumar, G. A., Rao, N. G., Prasad, K., Mathur, P., Pandian, J. D., Steinmetz, J. D., Biswas, A., Pal, P. K., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00164-9 · Cited by 179
Tick-borne encephalitis in China: A review of epidemiology and vaccines
Xing, Y., Schmitt, H., Arguedas, A. G., & Yang, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.015 · Cited by 70
Epidemiology of Japanese Encephalitis in the Philippines: A Systematic Review
Lopez, A. L., Aldaba, J. G., Roque, V. G., Tandoc, A. O., III, Sy, A. K., Espino, F. E., de Quiroz‐Castro, M., Jee, Y., Ducusin, M. J., & Fox, K. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003630 · Cited by 44
A review of the epidemiology, pathogenesis and management of tetanus
Mallick, I. H., & Winslet, M. C. (2004) · International Journal of Surgery · doi:10.1016/s1743-9191(06)60056-3 · Cited by 32
Divino-Goes, K. G., Moraes-Pinto, M. I. D., Dinelli, M. I. S., Casagrande, S. T., Bonetti, T. C. S., Andrade, P. R., & Weckx, L. Y. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006005000184 · Cited by 13
Cited by
Steinmetz, J. D., Seeher, K. M., Schiess, N., Nichols, E., Cao, B., Servili, C., Cavallera, V., Cousin, E., Hagins, H., Moberg, M. E., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00038-3 · Cited by 2,019
Gadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102357 · Cited by 358
A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
Chaparro, C. I. P., Simões, B. T., Borges, J. P., Castanho, M. A. R. B., Soares, P. I. P., & Neves, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092316 · Cited by 40
Tanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
NLRP1 inflammasome in neurodegenerative disorders: From pathology to therapies
Zhang, M.-J., Yang, L., Li, Z.-Y., Zhou, L.-Y., Wang, Y.-J., Wang, H.-S., Cui, X.-J., & Yao, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.10.004 · Cited by 21
Metadata
- Authors
- Ding, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z., Kang, D., Fang, W., & Chen, F.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-11-29
- Volume
- 10
- Pages
- 952161-952161
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W4310208502
- Cited by
- 311
- References
- 18
- FWCI
- 43.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.